Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients

Detalhes bibliográficos
Autor(a) principal: Silva, J. C.
Data de Publicação: 2015
Outros Autores: Aroso, Ivo Manuel Ascensão, Mano, F., Sá-Nogueira, I., Barreiros, S., Reis, R. L., Paiva, Alexandre, Duarte, Ana Rita C.
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/38328
Resumo: In recent years, deep eutectic solvents (DES) have emerged as a sustainable alternative to ionic liquids mainly due to their lower production costs and higher biodegradability/ biocompatibility(1). DES are defined as a mixture of organic compounds with a melting point significantly lower than that of either individual component(2). When based in natural compounds such as aminoacids, organic acids, sugars or choline derivatives, DES are so called natural deep eutectic solvents (NADES) which fully comply with green technology principles(3). NADES constituted by bioactive substances or active pharmaceutical ingredients (APIs), which we define as therapeutic deep eutectic solvents (THEDES), are a promising source for several pharmaceutical and biomedical applications due to their increased ability to dissolve model drugs by increasing their solubility, permeation and absorption. In this work, we synthetized several THEDES based in choline chloride (ChCl) or menthol conjugated with three different APIs: acetylsalicylic acid (AA), benzoic acid (BA) and phenylacetic acid (PA) with different molar ratios (ChCl:AA 1:1, ChCl:PA 1:1, Menthol:AA 3:1, Menthol:BA 3:1, Menthol:PA 2:1, Menthol:PA 3:1). All THEDES produced were characterized by differential scanning calorimetry and polarized optical microscopy. Dissolution studies performed in PBS for 24 hours shown that THEDES increased significantly the dissolution of all APIs studied compared to the control (APIs only). This increased solubility was even more noticeable for the cases of THEDES with menthol in their composition. In overall, our results suggest the great promise of using THEDES as solubility enhancers in the development of novel and more effective drug delivery systems.
id RCAP_3868cea287f4e1ce1cf0f7af213db2bb
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/38328
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredientsDrug delivery systemsGreen chemistryTherapeutic deep eutectic solventsCiências Médicas::Biotecnologia MédicaScience & TechnologyIn recent years, deep eutectic solvents (DES) have emerged as a sustainable alternative to ionic liquids mainly due to their lower production costs and higher biodegradability/ biocompatibility(1). DES are defined as a mixture of organic compounds with a melting point significantly lower than that of either individual component(2). When based in natural compounds such as aminoacids, organic acids, sugars or choline derivatives, DES are so called natural deep eutectic solvents (NADES) which fully comply with green technology principles(3). NADES constituted by bioactive substances or active pharmaceutical ingredients (APIs), which we define as therapeutic deep eutectic solvents (THEDES), are a promising source for several pharmaceutical and biomedical applications due to their increased ability to dissolve model drugs by increasing their solubility, permeation and absorption. In this work, we synthetized several THEDES based in choline chloride (ChCl) or menthol conjugated with three different APIs: acetylsalicylic acid (AA), benzoic acid (BA) and phenylacetic acid (PA) with different molar ratios (ChCl:AA 1:1, ChCl:PA 1:1, Menthol:AA 3:1, Menthol:BA 3:1, Menthol:PA 2:1, Menthol:PA 3:1). All THEDES produced were characterized by differential scanning calorimetry and polarized optical microscopy. Dissolution studies performed in PBS for 24 hours shown that THEDES increased significantly the dissolution of all APIs studied compared to the control (APIs only). This increased solubility was even more noticeable for the cases of THEDES with menthol in their composition. In overall, our results suggest the great promise of using THEDES as solubility enhancers in the development of novel and more effective drug delivery systems.Mary Ann LiebertUniversidade do MinhoSilva, J. C.Aroso, Ivo Manuel AscensãoMano, F.Sá-Nogueira, I.Barreiros, S.Reis, R. L.Paiva, AlexandreDuarte, Ana Rita C.2015-092015-09-01T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/1822/38328engSilva J. C., Aroso I. M., Mano F., Sá-Nogueira I., Barreiros S., Reis R. L., Paiva A., Duarte A. R. C. Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients, Tissue Engineering Part A, doi:10.1089/ten.tea.2015.5000.abstracts, 20151937-3341http://online.liebertpub.com/doi/full/10.1089/ten.tea.2015.5000.abstractsinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-11T05:16:18Zoai:repositorium.sdum.uminho.pt:1822/38328Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-11T05:16:18Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients
title Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients
spellingShingle Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients
Silva, J. C.
Drug delivery systems
Green chemistry
Therapeutic deep eutectic solvents
Ciências Médicas::Biotecnologia Médica
Science & Technology
title_short Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients
title_full Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients
title_fullStr Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients
title_full_unstemmed Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients
title_sort Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients
author Silva, J. C.
author_facet Silva, J. C.
Aroso, Ivo Manuel Ascensão
Mano, F.
Sá-Nogueira, I.
Barreiros, S.
Reis, R. L.
Paiva, Alexandre
Duarte, Ana Rita C.
author_role author
author2 Aroso, Ivo Manuel Ascensão
Mano, F.
Sá-Nogueira, I.
Barreiros, S.
Reis, R. L.
Paiva, Alexandre
Duarte, Ana Rita C.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Silva, J. C.
Aroso, Ivo Manuel Ascensão
Mano, F.
Sá-Nogueira, I.
Barreiros, S.
Reis, R. L.
Paiva, Alexandre
Duarte, Ana Rita C.
dc.subject.por.fl_str_mv Drug delivery systems
Green chemistry
Therapeutic deep eutectic solvents
Ciências Médicas::Biotecnologia Médica
Science & Technology
topic Drug delivery systems
Green chemistry
Therapeutic deep eutectic solvents
Ciências Médicas::Biotecnologia Médica
Science & Technology
description In recent years, deep eutectic solvents (DES) have emerged as a sustainable alternative to ionic liquids mainly due to their lower production costs and higher biodegradability/ biocompatibility(1). DES are defined as a mixture of organic compounds with a melting point significantly lower than that of either individual component(2). When based in natural compounds such as aminoacids, organic acids, sugars or choline derivatives, DES are so called natural deep eutectic solvents (NADES) which fully comply with green technology principles(3). NADES constituted by bioactive substances or active pharmaceutical ingredients (APIs), which we define as therapeutic deep eutectic solvents (THEDES), are a promising source for several pharmaceutical and biomedical applications due to their increased ability to dissolve model drugs by increasing their solubility, permeation and absorption. In this work, we synthetized several THEDES based in choline chloride (ChCl) or menthol conjugated with three different APIs: acetylsalicylic acid (AA), benzoic acid (BA) and phenylacetic acid (PA) with different molar ratios (ChCl:AA 1:1, ChCl:PA 1:1, Menthol:AA 3:1, Menthol:BA 3:1, Menthol:PA 2:1, Menthol:PA 3:1). All THEDES produced were characterized by differential scanning calorimetry and polarized optical microscopy. Dissolution studies performed in PBS for 24 hours shown that THEDES increased significantly the dissolution of all APIs studied compared to the control (APIs only). This increased solubility was even more noticeable for the cases of THEDES with menthol in their composition. In overall, our results suggest the great promise of using THEDES as solubility enhancers in the development of novel and more effective drug delivery systems.
publishDate 2015
dc.date.none.fl_str_mv 2015-09
2015-09-01T00:00:00Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/38328
url http://hdl.handle.net/1822/38328
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Silva J. C., Aroso I. M., Mano F., Sá-Nogueira I., Barreiros S., Reis R. L., Paiva A., Duarte A. R. C. Therapeutic deep eutectic solvents as solubility enhancers for different active pharmaceutical ingredients, Tissue Engineering Part A, doi:10.1089/ten.tea.2015.5000.abstracts, 2015
1937-3341
http://online.liebertpub.com/doi/full/10.1089/ten.tea.2015.5000.abstracts
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Mary Ann Liebert
publisher.none.fl_str_mv Mary Ann Liebert
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817544568144396288